nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—HTR2C—obesity	0.109	0.406	CbGaD
Trifluoperazine—DRD2—obesity	0.0897	0.335	CbGaD
Trifluoperazine—Ethopropazine—Diethylpropion—obesity	0.0832	0.339	CrCrCtD
Trifluoperazine—HTR2A—obesity	0.0693	0.259	CbGaD
Trifluoperazine—ADRA1A—Phendimetrazine—obesity	0.0617	0.267	CbGbCtD
Trifluoperazine—Ethopropazine—Benzphetamine—obesity	0.0486	0.198	CrCrCtD
Trifluoperazine—ADRA1A—Benzphetamine—obesity	0.0467	0.202	CbGbCtD
Trifluoperazine—ADRA1A—Phenylpropanolamine—obesity	0.0446	0.193	CbGbCtD
Trifluoperazine—Promethazine—Benzphetamine—obesity	0.0402	0.164	CrCrCtD
Trifluoperazine—Alimemazine—Benzphetamine—obesity	0.0395	0.161	CrCrCtD
Trifluoperazine—Promazine—Benzphetamine—obesity	0.034	0.139	CrCrCtD
Trifluoperazine—CYP1A2—Phentermine—obesity	0.0197	0.0851	CbGbCtD
Trifluoperazine—CYP1A2—Phenylpropanolamine—obesity	0.0188	0.0812	CbGbCtD
Trifluoperazine—CYP1A2—Bupropion—obesity	0.0167	0.0724	CbGbCtD
Trifluoperazine—CYP1A2—Cimetidine—obesity	0.0123	0.0531	CbGbCtD
Trifluoperazine—ABCB1—Cimetidine—obesity	0.0107	0.0464	CbGbCtD
Trifluoperazine—CALM1—sympathetic nervous system—obesity	0.00204	0.0388	CbGeAlD
Trifluoperazine—EBPL—respiratory system—obesity	0.00156	0.0297	CbGeAlD
Trifluoperazine—CALY—islet of Langerhans—obesity	0.00151	0.0288	CbGeAlD
Trifluoperazine—CALM1—autonomic nervous system—obesity	0.00137	0.0261	CbGeAlD
Trifluoperazine—S100A4—islet of Langerhans—obesity	0.0013	0.0248	CbGeAlD
Trifluoperazine—HTR2A—sympathetic nervous system—obesity	0.00124	0.0237	CbGeAlD
Trifluoperazine—S100A4—respiratory system—obesity	0.00123	0.0234	CbGeAlD
Trifluoperazine—HTR2A—vagus nerve—obesity	0.0012	0.0229	CbGeAlD
Trifluoperazine—UGT1A4—respiratory system—obesity	0.00108	0.0206	CbGeAlD
Trifluoperazine—EBPL—adipose tissue—obesity	0.00105	0.0201	CbGeAlD
Trifluoperazine—S100A4—adrenal cortex—obesity	0.00103	0.0197	CbGeAlD
Trifluoperazine—CALY—pituitary gland—obesity	0.000966	0.0184	CbGeAlD
Trifluoperazine—EBPL—adrenal gland—obesity	0.000944	0.018	CbGeAlD
Trifluoperazine—S100A4—cardiovascular system—obesity	0.000942	0.018	CbGeAlD
Trifluoperazine—TNNC1—adrenal cortex—obesity	0.000869	0.0166	CbGeAlD
Trifluoperazine—HTR2A—autonomic nervous system—obesity	0.000835	0.0159	CbGeAlD
Trifluoperazine—S100A4—pituitary gland—obesity	0.000834	0.0159	CbGeAlD
Trifluoperazine—S100A4—adipose tissue—obesity	0.000831	0.0158	CbGeAlD
Trifluoperazine—EBPL—endocrine gland—obesity	0.000818	0.0156	CbGeAlD
Trifluoperazine—TNNC1—cardiovascular system—obesity	0.000793	0.0151	CbGeAlD
Trifluoperazine—EBP—endocrine gland—obesity	0.000785	0.015	CbGeAlD
Trifluoperazine—S100A4—digestive system—obesity	0.000782	0.0149	CbGeAlD
Trifluoperazine—CALY—endocrine gland—obesity	0.000749	0.0143	CbGeAlD
Trifluoperazine—S100A4—adrenal gland—obesity	0.000745	0.0142	CbGeAlD
Trifluoperazine—EBPL—liver—obesity	0.000738	0.0141	CbGeAlD
Trifluoperazine—EBP—liver—obesity	0.000707	0.0135	CbGeAlD
Trifluoperazine—TNNC1—pituitary gland—obesity	0.000702	0.0134	CbGeAlD
Trifluoperazine—TNNC1—adipose tissue—obesity	0.000699	0.0133	CbGeAlD
Trifluoperazine—UGT1A4—digestive system—obesity	0.000687	0.0131	CbGeAlD
Trifluoperazine—S100A4—endocrine gland—obesity	0.000646	0.0123	CbGeAlD
Trifluoperazine—TNNC1—adrenal gland—obesity	0.000627	0.012	CbGeAlD
Trifluoperazine—HTR1A—hindbrain—obesity	0.00059	0.0112	CbGeAlD
Trifluoperazine—S100A4—liver—obesity	0.000583	0.0111	CbGeAlD
Trifluoperazine—CALM2—hindbrain—obesity	0.00058	0.0111	CbGeAlD
Trifluoperazine—CALM1—hindbrain—obesity	0.000577	0.011	CbGeAlD
Trifluoperazine—CALM2—gall bladder—obesity	0.000572	0.0109	CbGeAlD
Trifluoperazine—UGT1A4—endocrine gland—obesity	0.000567	0.0108	CbGeAlD
Trifluoperazine—ADRA1A—hindbrain—obesity	0.000544	0.0104	CbGeAlD
Trifluoperazine—DRD2—hindbrain—obesity	0.000533	0.0102	CbGeAlD
Trifluoperazine—UGT1A4—liver—obesity	0.000511	0.00975	CbGeAlD
Trifluoperazine—XDH—digestive system—obesity	0.000501	0.00955	CbGeAlD
Trifluoperazine—CALM3—islet of Langerhans—obesity	0.000477	0.0091	CbGeAlD
Trifluoperazine—SIGMAR1—islet of Langerhans—obesity	0.000427	0.00814	CbGeAlD
Trifluoperazine—XDH—endocrine gland—obesity	0.000414	0.00789	CbGeAlD
Trifluoperazine—Vision blurred—Phenylpropanolamine—obesity	0.000414	0.00437	CcSEcCtD
Trifluoperazine—Tremor—Phenylpropanolamine—obesity	0.000411	0.00434	CcSEcCtD
Trifluoperazine—Constipation—Methamphetamine—obesity	0.000408	0.00431	CcSEcCtD
Trifluoperazine—Nervousness—Phentermine—obesity	0.000408	0.00431	CcSEcCtD
Trifluoperazine—Agitation—Phenylpropanolamine—obesity	0.000403	0.00426	CcSEcCtD
Trifluoperazine—Decreased appetite—Benzphetamine—obesity	0.0004	0.00423	CcSEcCtD
Trifluoperazine—Anorexia—Phendimetrazine—obesity	0.0004	0.00422	CcSEcCtD
Trifluoperazine—Dyskinesia—Bupropion—obesity	0.000394	0.00416	CcSEcCtD
Trifluoperazine—Tremor—Phentermine—obesity	0.000393	0.00416	CcSEcCtD
Trifluoperazine—Agitation—Phentermine—obesity	0.000386	0.00408	CcSEcCtD
Trifluoperazine—Insomnia—Phendimetrazine—obesity	0.000379	0.00401	CcSEcCtD
Trifluoperazine—Urticaria—Methamphetamine—obesity	0.000379	0.004	CcSEcCtD
Trifluoperazine—CALM3—adrenal cortex—obesity	0.000378	0.00721	CbGeAlD
Trifluoperazine—CALM2—islet of Langerhans—obesity	0.000375	0.00715	CbGeAlD
Trifluoperazine—CALM1—islet of Langerhans—obesity	0.000373	0.00712	CbGeAlD
Trifluoperazine—XDH—liver—obesity	0.000373	0.00711	CbGeAlD
Trifluoperazine—Hepatocellular injury—Bupropion—obesity	0.00037	0.00391	CcSEcCtD
Trifluoperazine—Urticaria—Benzphetamine—obesity	0.000365	0.00386	CcSEcCtD
Trifluoperazine—Erythema—Diethylpropion—obesity	0.000365	0.00386	CcSEcCtD
Trifluoperazine—Decreased appetite—Phendimetrazine—obesity	0.000364	0.00385	CcSEcCtD
Trifluoperazine—Constipation—Phendimetrazine—obesity	0.000358	0.00379	CcSEcCtD
Trifluoperazine—Nervousness—Diethylpropion—obesity	0.000355	0.00375	CcSEcCtD
Trifluoperazine—Eczema—Orlistat—obesity	0.000355	0.00375	CcSEcCtD
Trifluoperazine—CALM2—respiratory system—obesity	0.000354	0.00675	CbGeAlD
Trifluoperazine—CALM1—respiratory system—obesity	0.000352	0.00672	CbGeAlD
Trifluoperazine—HTR2A—hindbrain—obesity	0.000352	0.0067	CbGeAlD
Trifluoperazine—Hypersensitivity—Methamphetamine—obesity	0.000351	0.00371	CcSEcCtD
Trifluoperazine—Photosensitivity—Sibutramine—obesity	0.000351	0.00371	CcSEcCtD
Trifluoperazine—Dry mouth—Phentermine—obesity	0.00035	0.0037	CcSEcCtD
Trifluoperazine—Vision blurred—Diethylpropion—obesity	0.000344	0.00364	CcSEcCtD
Trifluoperazine—Eczema—Sibutramine—obesity	0.000343	0.00363	CcSEcCtD
Trifluoperazine—Tremor—Diethylpropion—obesity	0.000342	0.00362	CcSEcCtD
Trifluoperazine—CHRM2—cardiovascular system—obesity	0.00034	0.00648	CbGeAlD
Trifluoperazine—Increased appetite—Orlistat—obesity	0.000339	0.00358	CcSEcCtD
Trifluoperazine—Hypersensitivity—Benzphetamine—obesity	0.000339	0.00358	CcSEcCtD
Trifluoperazine—Nasal congestion—Sibutramine—obesity	0.000339	0.00358	CcSEcCtD
Trifluoperazine—SIGMAR1—adrenal cortex—obesity	0.000338	0.00645	CbGeAlD
Trifluoperazine—Agitation—Diethylpropion—obesity	0.000336	0.00355	CcSEcCtD
Trifluoperazine—Hypotension—Phenylpropanolamine—obesity	0.000335	0.00354	CcSEcCtD
Trifluoperazine—Gynaecomastia—Bupropion—obesity	0.000331	0.0035	CcSEcCtD
Trifluoperazine—Increased appetite—Sibutramine—obesity	0.000328	0.00347	CcSEcCtD
Trifluoperazine—Leukopenia—Diethylpropion—obesity	0.000327	0.00346	CcSEcCtD
Trifluoperazine—Hypoglycaemia—Orlistat—obesity	0.000326	0.00345	CcSEcCtD
Trifluoperazine—DRD2—respiratory system—obesity	0.000326	0.00621	CbGeAlD
Trifluoperazine—Insomnia—Phenylpropanolamine—obesity	0.000324	0.00342	CcSEcCtD
Trifluoperazine—Agitation—Cimetidine—obesity	0.000319	0.00338	CcSEcCtD
Trifluoperazine—Dyspnoea—Phenylpropanolamine—obesity	0.000319	0.00337	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Sibutramine—obesity	0.000319	0.00337	CcSEcCtD
Trifluoperazine—Somnolence—Phenylpropanolamine—obesity	0.000318	0.00336	CcSEcCtD
Trifluoperazine—Convulsion—Diethylpropion—obesity	0.000316	0.00335	CcSEcCtD
Trifluoperazine—Hypoglycaemia—Sibutramine—obesity	0.000316	0.00334	CcSEcCtD
Trifluoperazine—Dizziness—Methamphetamine—obesity	0.000315	0.00333	CcSEcCtD
Trifluoperazine—Leukopenia—Cimetidine—obesity	0.000311	0.00329	CcSEcCtD
Trifluoperazine—Insomnia—Phentermine—obesity	0.00031	0.00328	CcSEcCtD
Trifluoperazine—Constipation—Phenylpropanolamine—obesity	0.000306	0.00324	CcSEcCtD
Trifluoperazine—Photosensitivity—Bupropion—obesity	0.000306	0.00324	CcSEcCtD
Trifluoperazine—CALM3—pituitary gland—obesity	0.000306	0.00583	CbGeAlD
Trifluoperazine—CALM3—adipose tissue—obesity	0.000305	0.00581	CbGeAlD
Trifluoperazine—Dizziness—Benzphetamine—obesity	0.000304	0.00321	CcSEcCtD
Trifluoperazine—Dry mouth—Diethylpropion—obesity	0.000304	0.00321	CcSEcCtD
Trifluoperazine—Eczema—Bupropion—obesity	0.000299	0.00316	CcSEcCtD
Trifluoperazine—Headache—Methamphetamine—obesity	0.000299	0.00316	CcSEcCtD
Trifluoperazine—CALM2—adrenal cortex—obesity	0.000297	0.00566	CbGeAlD
Trifluoperazine—Mydriasis—Topiramate—obesity	0.000296	0.00313	CcSEcCtD
Trifluoperazine—CALM1—adrenal cortex—obesity	0.000296	0.00564	CbGeAlD
Trifluoperazine—Fatigue—Phentermine—obesity	0.000295	0.00312	CcSEcCtD
Trifluoperazine—Nasal congestion—Bupropion—obesity	0.000295	0.00312	CcSEcCtD
Trifluoperazine—Urinary retention—Sibutramine—obesity	0.000293	0.0031	CcSEcCtD
Trifluoperazine—Cardiac arrest—Sibutramine—obesity	0.000293	0.0031	CcSEcCtD
Trifluoperazine—Constipation—Phentermine—obesity	0.000293	0.0031	CcSEcCtD
Trifluoperazine—Headache—Benzphetamine—obesity	0.000288	0.00305	CcSEcCtD
Trifluoperazine—Increased appetite—Bupropion—obesity	0.000286	0.00302	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Bupropion—obesity	0.000285	0.00301	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Cimetidine—obesity	0.000284	0.003	CcSEcCtD
Trifluoperazine—Dizziness—Phendimetrazine—obesity	0.000277	0.00293	CcSEcCtD
Trifluoperazine—HTR1A—cardiovascular system—obesity	0.000276	0.00526	CbGeAlD
Trifluoperazine—Hypoglycaemia—Bupropion—obesity	0.000275	0.00291	CcSEcCtD
Trifluoperazine—Asthma—Orlistat—obesity	0.000275	0.00291	CcSEcCtD
Trifluoperazine—CYP1A2—respiratory system—obesity	0.000275	0.00523	CbGeAlD
Trifluoperazine—SIGMAR1—pituitary gland—obesity	0.000273	0.00521	CbGeAlD
Trifluoperazine—Nausea—Benzphetamine—obesity	0.000273	0.00289	CcSEcCtD
Trifluoperazine—CALM3—adrenal gland—obesity	0.000273	0.00521	CbGeAlD
Trifluoperazine—Urticaria—Phentermine—obesity	0.000272	0.00288	CcSEcCtD
Trifluoperazine—SIGMAR1—adipose tissue—obesity	0.000272	0.00519	CbGeAlD
Trifluoperazine—Muscular weakness—Sibutramine—obesity	0.000272	0.00287	CcSEcCtD
Trifluoperazine—CALM2—cardiovascular system—obesity	0.000271	0.00517	CbGeAlD
Trifluoperazine—Bronchospasm—Orlistat—obesity	0.000271	0.00286	CcSEcCtD
Trifluoperazine—CALM1—cardiovascular system—obesity	0.00027	0.00515	CbGeAlD
Trifluoperazine—Insomnia—Diethylpropion—obesity	0.00027	0.00285	CcSEcCtD
Trifluoperazine—Amenorrhoea—Topiramate—obesity	0.000269	0.00284	CcSEcCtD
Trifluoperazine—Asthma—Sibutramine—obesity	0.000267	0.00282	CcSEcCtD
Trifluoperazine—Dysphagia—Sibutramine—obesity	0.000267	0.00282	CcSEcCtD
Trifluoperazine—Dyspnoea—Diethylpropion—obesity	0.000266	0.00281	CcSEcCtD
Trifluoperazine—Somnolence—Diethylpropion—obesity	0.000265	0.0028	CcSEcCtD
Trifluoperazine—Eosinophilia—Sibutramine—obesity	0.000264	0.00279	CcSEcCtD
Trifluoperazine—Hypersensitivity—Phenylpropanolamine—obesity	0.000264	0.00279	CcSEcCtD
Trifluoperazine—Headache—Phendimetrazine—obesity	0.000263	0.00278	CcSEcCtD
Trifluoperazine—HRH1—respiratory system—obesity	0.000257	0.0049	CbGeAlD
Trifluoperazine—Urinary retention—Bupropion—obesity	0.000256	0.0027	CcSEcCtD
Trifluoperazine—Constipation—Diethylpropion—obesity	0.000255	0.00269	CcSEcCtD
Trifluoperazine—ADRA1A—cardiovascular system—obesity	0.000254	0.00485	CbGeAlD
Trifluoperazine—Somnolence—Cimetidine—obesity	0.000252	0.00267	CcSEcCtD
Trifluoperazine—Dyskinesia—Topiramate—obesity	0.000251	0.00265	CcSEcCtD
Trifluoperazine—Nausea—Phendimetrazine—obesity	0.000249	0.00263	CcSEcCtD
Trifluoperazine—Asthenia—Phentermine—obesity	0.000246	0.0026	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Sibutramine—obesity	0.000245	0.00259	CcSEcCtD
Trifluoperazine—Fatigue—Cimetidine—obesity	0.000245	0.00258	CcSEcCtD
Trifluoperazine—SIGMAR1—adrenal gland—obesity	0.000244	0.00465	CbGeAlD
Trifluoperazine—Photosensitivity reaction—Sibutramine—obesity	0.000243	0.00257	CcSEcCtD
Trifluoperazine—Constipation—Cimetidine—obesity	0.000243	0.00256	CcSEcCtD
Trifluoperazine—Weight increased—Sibutramine—obesity	0.000243	0.00256	CcSEcCtD
Trifluoperazine—Gait disturbance—Topiramate—obesity	0.000242	0.00256	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Sibutramine—obesity	0.00024	0.00254	CcSEcCtD
Trifluoperazine—CALM2—pituitary gland—obesity	0.00024	0.00458	CbGeAlD
Trifluoperazine—CALM2—adipose tissue—obesity	0.000239	0.00456	CbGeAlD
Trifluoperazine—CALM1—pituitary gland—obesity	0.000239	0.00456	CbGeAlD
Trifluoperazine—CALM1—adipose tissue—obesity	0.000238	0.00454	CbGeAlD
Trifluoperazine—Muscular weakness—Bupropion—obesity	0.000237	0.00251	CcSEcCtD
Trifluoperazine—Urticaria—Diethylpropion—obesity	0.000237	0.0025	CcSEcCtD
Trifluoperazine—Dizziness—Phenylpropanolamine—obesity	0.000237	0.0025	CcSEcCtD
Trifluoperazine—CHRM2—endocrine gland—obesity	0.000233	0.00445	CbGeAlD
Trifluoperazine—Asthma—Bupropion—obesity	0.000232	0.00246	CcSEcCtD
Trifluoperazine—Dysphagia—Bupropion—obesity	0.000232	0.00246	CcSEcCtD
Trifluoperazine—Bronchospasm—Bupropion—obesity	0.000229	0.00242	CcSEcCtD
Trifluoperazine—Dizziness—Phentermine—obesity	0.000227	0.0024	CcSEcCtD
Trifluoperazine—Rash—Phenylpropanolamine—obesity	0.000226	0.00239	CcSEcCtD
Trifluoperazine—Dermatitis—Phenylpropanolamine—obesity	0.000226	0.00238	CcSEcCtD
Trifluoperazine—CALM2—digestive system—obesity	0.000225	0.00429	CbGeAlD
Trifluoperazine—ADRA1A—adipose tissue—obesity	0.000224	0.00428	CbGeAlD
Trifluoperazine—Body temperature increased—Cimetidine—obesity	0.000224	0.00237	CcSEcCtD
Trifluoperazine—CALM1—digestive system—obesity	0.000224	0.00427	CbGeAlD
Trifluoperazine—DRD2—pituitary gland—obesity	0.000221	0.00421	CbGeAlD
Trifluoperazine—Pancytopenia—Bupropion—obesity	0.000221	0.00233	CcSEcCtD
Trifluoperazine—HTR1A—adrenal gland—obesity	0.000218	0.00416	CbGeAlD
Trifluoperazine—Oedema peripheral—Orlistat—obesity	0.000217	0.0023	CcSEcCtD
Trifluoperazine—Rash—Phentermine—obesity	0.000216	0.00228	CcSEcCtD
Trifluoperazine—Dermatitis—Phentermine—obesity	0.000216	0.00228	CcSEcCtD
Trifluoperazine—HTR2A—respiratory system—obesity	0.000215	0.00409	CbGeAlD
Trifluoperazine—Headache—Phentermine—obesity	0.000215	0.00227	CcSEcCtD
Trifluoperazine—CALM2—adrenal gland—obesity	0.000215	0.00409	CbGeAlD
Trifluoperazine—Erectile dysfunction—Bupropion—obesity	0.000214	0.00226	CcSEcCtD
Trifluoperazine—CALM3—liver—obesity	0.000214	0.00407	CbGeAlD
Trifluoperazine—CALM1—adrenal gland—obesity	0.000214	0.00407	CbGeAlD
Trifluoperazine—Nausea—Phenylpropanolamine—obesity	0.000213	0.00225	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Bupropion—obesity	0.000212	0.00224	CcSEcCtD
Trifluoperazine—Weight increased—Bupropion—obesity	0.000211	0.00223	CcSEcCtD
Trifluoperazine—Oedema peripheral—Sibutramine—obesity	0.00021	0.00222	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Bupropion—obesity	0.00021	0.00222	CcSEcCtD
Trifluoperazine—Hypersensitivity—Cimetidine—obesity	0.000209	0.00221	CcSEcCtD
Trifluoperazine—Nausea—Phentermine—obesity	0.000204	0.00215	CcSEcCtD
Trifluoperazine—Asthenia—Cimetidine—obesity	0.000204	0.00215	CcSEcCtD
Trifluoperazine—Jaundice—Bupropion—obesity	0.000202	0.00213	CcSEcCtD
Trifluoperazine—ADRA1A—adrenal gland—obesity	0.000201	0.00384	CbGeAlD
Trifluoperazine—Dizziness—Diethylpropion—obesity	0.000197	0.00208	CcSEcCtD
Trifluoperazine—SIGMAR1—liver—obesity	0.000191	0.00364	CbGeAlD
Trifluoperazine—Eczema—Topiramate—obesity	0.000191	0.00201	CcSEcCtD
Trifluoperazine—HTR1A—endocrine gland—obesity	0.000189	0.00361	CbGeAlD
Trifluoperazine—Nasal congestion—Topiramate—obesity	0.000188	0.00199	CcSEcCtD
Trifluoperazine—Rash—Diethylpropion—obesity	0.000188	0.00199	CcSEcCtD
Trifluoperazine—Dermatitis—Diethylpropion—obesity	0.000188	0.00198	CcSEcCtD
Trifluoperazine—Dizziness—Cimetidine—obesity	0.000188	0.00198	CcSEcCtD
Trifluoperazine—Headache—Diethylpropion—obesity	0.000187	0.00197	CcSEcCtD
Trifluoperazine—CALM2—endocrine gland—obesity	0.000186	0.00355	CbGeAlD
Trifluoperazine—CALM1—endocrine gland—obesity	0.000185	0.00353	CbGeAlD
Trifluoperazine—Muscle spasms—Orlistat—obesity	0.000184	0.00195	CcSEcCtD
Trifluoperazine—Oedema peripheral—Bupropion—obesity	0.000183	0.00194	CcSEcCtD
Trifluoperazine—Increased appetite—Topiramate—obesity	0.000182	0.00193	CcSEcCtD
Trifluoperazine—Vision blurred—Orlistat—obesity	0.000181	0.00191	CcSEcCtD
Trifluoperazine—Nervousness—Sibutramine—obesity	0.00018	0.00191	CcSEcCtD
Trifluoperazine—Rash—Cimetidine—obesity	0.000179	0.00189	CcSEcCtD
Trifluoperazine—Dermatitis—Cimetidine—obesity	0.000179	0.00189	CcSEcCtD
Trifluoperazine—Muscle spasms—Sibutramine—obesity	0.000179	0.00189	CcSEcCtD
Trifluoperazine—Headache—Cimetidine—obesity	0.000178	0.00188	CcSEcCtD
Trifluoperazine—Nausea—Diethylpropion—obesity	0.000177	0.00187	CcSEcCtD
Trifluoperazine—Hypoglycaemia—Topiramate—obesity	0.000176	0.00185	CcSEcCtD
Trifluoperazine—Angioedema—Orlistat—obesity	0.000175	0.00185	CcSEcCtD
Trifluoperazine—Vision blurred—Sibutramine—obesity	0.000175	0.00185	CcSEcCtD
Trifluoperazine—CYP1A2—digestive system—obesity	0.000175	0.00333	CbGeAlD
Trifluoperazine—ADRA1A—endocrine gland—obesity	0.000174	0.00333	CbGeAlD
Trifluoperazine—Tremor—Sibutramine—obesity	0.000174	0.00184	CcSEcCtD
Trifluoperazine—HRH1—adipose tissue—obesity	0.000174	0.00331	CbGeAlD
Trifluoperazine—DRD2—endocrine gland—obesity	0.000171	0.00326	CbGeAlD
Trifluoperazine—Agitation—Sibutramine—obesity	0.000171	0.0018	CcSEcCtD
Trifluoperazine—Angioedema—Sibutramine—obesity	0.00017	0.00179	CcSEcCtD
Trifluoperazine—Nausea—Cimetidine—obesity	0.000168	0.00178	CcSEcCtD
Trifluoperazine—CALM2—liver—obesity	0.000168	0.0032	CbGeAlD
Trifluoperazine—Cough—Orlistat—obesity	0.000167	0.00177	CcSEcCtD
Trifluoperazine—CALM1—liver—obesity	0.000167	0.00318	CbGeAlD
Trifluoperazine—Convulsion—Orlistat—obesity	0.000166	0.00176	CcSEcCtD
Trifluoperazine—Leukopenia—Sibutramine—obesity	0.000166	0.00176	CcSEcCtD
Trifluoperazine—HTR2A—cardiovascular system—obesity	0.000164	0.00313	CbGeAlD
Trifluoperazine—HRH1—digestive system—obesity	0.000163	0.00312	CbGeAlD
Trifluoperazine—Urinary retention—Topiramate—obesity	0.000163	0.00172	CcSEcCtD
Trifluoperazine—Cough—Sibutramine—obesity	0.000162	0.00171	CcSEcCtD
Trifluoperazine—Convulsion—Sibutramine—obesity	0.000161	0.0017	CcSEcCtD
Trifluoperazine—Dry mouth—Orlistat—obesity	0.00016	0.00169	CcSEcCtD
Trifluoperazine—ADRA1A—liver—obesity	0.000157	0.003	CbGeAlD
Trifluoperazine—Nervousness—Bupropion—obesity	0.000157	0.00166	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Orlistat—obesity	0.000157	0.00166	CcSEcCtD
Trifluoperazine—HRH1—adrenal gland—obesity	0.000156	0.00297	CbGeAlD
Trifluoperazine—Muscle spasms—Bupropion—obesity	0.000156	0.00165	CcSEcCtD
Trifluoperazine—Dry mouth—Sibutramine—obesity	0.000155	0.00163	CcSEcCtD
Trifluoperazine—Vision blurred—Bupropion—obesity	0.000153	0.00161	CcSEcCtD
Trifluoperazine—Skin disorder—Orlistat—obesity	0.000152	0.00161	CcSEcCtD
Trifluoperazine—Tremor—Bupropion—obesity	0.000152	0.0016	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Sibutramine—obesity	0.000152	0.0016	CcSEcCtD
Trifluoperazine—Muscular weakness—Topiramate—obesity	0.000151	0.0016	CcSEcCtD
Trifluoperazine—ABCB1—islet of Langerhans—obesity	0.000149	0.00284	CbGeAlD
Trifluoperazine—Agitation—Bupropion—obesity	0.000149	0.00157	CcSEcCtD
Trifluoperazine—Asthma—Topiramate—obesity	0.000148	0.00156	CcSEcCtD
Trifluoperazine—Dysphagia—Topiramate—obesity	0.000148	0.00156	CcSEcCtD
Trifluoperazine—Angioedema—Bupropion—obesity	0.000148	0.00156	CcSEcCtD
Trifluoperazine—Skin disorder—Sibutramine—obesity	0.000147	0.00156	CcSEcCtD
Trifluoperazine—Eosinophilia—Topiramate—obesity	0.000147	0.00155	CcSEcCtD
Trifluoperazine—HTR2A—pituitary gland—obesity	0.000146	0.00278	CbGeAlD
Trifluoperazine—Leukopenia—Bupropion—obesity	0.000145	0.00153	CcSEcCtD
Trifluoperazine—Anorexia—Sibutramine—obesity	0.000144	0.00153	CcSEcCtD
Trifluoperazine—CYP1A2—endocrine gland—obesity	0.000144	0.00275	CbGeAlD
Trifluoperazine—Insomnia—Orlistat—obesity	0.000142	0.0015	CcSEcCtD
Trifluoperazine—Hypotension—Sibutramine—obesity	0.000142	0.0015	CcSEcCtD
Trifluoperazine—Cough—Bupropion—obesity	0.000141	0.00149	CcSEcCtD
Trifluoperazine—ABCB1—respiratory system—obesity	0.000141	0.00268	CbGeAlD
Trifluoperazine—Pancytopenia—Topiramate—obesity	0.000141	0.00149	CcSEcCtD
Trifluoperazine—Convulsion—Bupropion—obesity	0.00014	0.00148	CcSEcCtD
Trifluoperazine—Insomnia—Sibutramine—obesity	0.000137	0.00145	CcSEcCtD
Trifluoperazine—HTR2A—digestive system—obesity	0.000137	0.0026	CbGeAlD
Trifluoperazine—Erectile dysfunction—Topiramate—obesity	0.000136	0.00144	CcSEcCtD
Trifluoperazine—Decreased appetite—Orlistat—obesity	0.000136	0.00144	CcSEcCtD
Trifluoperazine—Dyspnoea—Sibutramine—obesity	0.000135	0.00143	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Topiramate—obesity	0.000135	0.00143	CcSEcCtD
Trifluoperazine—HRH1—endocrine gland—obesity	0.000135	0.00257	CbGeAlD
Trifluoperazine—Fatigue—Orlistat—obesity	0.000135	0.00143	CcSEcCtD
Trifluoperazine—Dry mouth—Bupropion—obesity	0.000135	0.00142	CcSEcCtD
Trifluoperazine—Somnolence—Sibutramine—obesity	0.000135	0.00142	CcSEcCtD
Trifluoperazine—Weight increased—Topiramate—obesity	0.000135	0.00142	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Topiramate—obesity	0.000134	0.00141	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Bupropion—obesity	0.000132	0.0014	CcSEcCtD
Trifluoperazine—Decreased appetite—Sibutramine—obesity	0.000132	0.00139	CcSEcCtD
Trifluoperazine—HTR2A—adrenal gland—obesity	0.00013	0.00248	CbGeAlD
Trifluoperazine—CYP1A2—liver—obesity	0.00013	0.00248	CbGeAlD
Trifluoperazine—Constipation—Sibutramine—obesity	0.00013	0.00137	CcSEcCtD
Trifluoperazine—Skin disorder—Bupropion—obesity	0.000128	0.00136	CcSEcCtD
Trifluoperazine—Anorexia—Bupropion—obesity	0.000126	0.00133	CcSEcCtD
Trifluoperazine—Urticaria—Orlistat—obesity	0.000124	0.00131	CcSEcCtD
Trifluoperazine—Body temperature increased—Orlistat—obesity	0.000124	0.00131	CcSEcCtD
Trifluoperazine—Hypotension—Bupropion—obesity	0.000123	0.0013	CcSEcCtD
Trifluoperazine—Agranulocytosis—Topiramate—obesity	0.000123	0.0013	CcSEcCtD
Trifluoperazine—Urticaria—Sibutramine—obesity	0.00012	0.00127	CcSEcCtD
Trifluoperazine—Body temperature increased—Sibutramine—obesity	0.00012	0.00127	CcSEcCtD
Trifluoperazine—Insomnia—Bupropion—obesity	0.00012	0.00126	CcSEcCtD
Trifluoperazine—ABCB1—adrenal cortex—obesity	0.000118	0.00225	CbGeAlD
Trifluoperazine—Dyspnoea—Bupropion—obesity	0.000118	0.00125	CcSEcCtD
Trifluoperazine—Somnolence—Bupropion—obesity	0.000117	0.00124	CcSEcCtD
Trifluoperazine—Oedema peripheral—Topiramate—obesity	0.000117	0.00123	CcSEcCtD
Trifluoperazine—Hypersensitivity—Orlistat—obesity	0.000115	0.00122	CcSEcCtD
Trifluoperazine—Decreased appetite—Bupropion—obesity	0.000115	0.00121	CcSEcCtD
Trifluoperazine—Fatigue—Bupropion—obesity	0.000114	0.0012	CcSEcCtD
Trifluoperazine—Constipation—Bupropion—obesity	0.000113	0.00119	CcSEcCtD
Trifluoperazine—HTR2A—endocrine gland—obesity	0.000113	0.00215	CbGeAlD
Trifluoperazine—Asthenia—Orlistat—obesity	0.000112	0.00119	CcSEcCtD
Trifluoperazine—Hypersensitivity—Sibutramine—obesity	0.000112	0.00118	CcSEcCtD
Trifluoperazine—Pruritus—Orlistat—obesity	0.000111	0.00117	CcSEcCtD
Trifluoperazine—Asthenia—Sibutramine—obesity	0.000109	0.00115	CcSEcCtD
Trifluoperazine—ABCB1—cardiovascular system—obesity	0.000108	0.00205	CbGeAlD
Trifluoperazine—Pruritus—Sibutramine—obesity	0.000107	0.00113	CcSEcCtD
Trifluoperazine—Urticaria—Bupropion—obesity	0.000105	0.00111	CcSEcCtD
Trifluoperazine—Body temperature increased—Bupropion—obesity	0.000104	0.0011	CcSEcCtD
Trifluoperazine—Dizziness—Orlistat—obesity	0.000104	0.00109	CcSEcCtD
Trifluoperazine—Erythema—Topiramate—obesity	0.000103	0.00109	CcSEcCtD
Trifluoperazine—HTR2A—liver—obesity	0.000102	0.00194	CbGeAlD
Trifluoperazine—Flupentixol—DRD1—obesity	0.000102	0.0249	CrCbGaD
Trifluoperazine—Dizziness—Sibutramine—obesity	0.0001	0.00106	CcSEcCtD
Trifluoperazine—Nervousness—Topiramate—obesity	0.0001	0.00106	CcSEcCtD
Trifluoperazine—Muscle spasms—Topiramate—obesity	9.92e-05	0.00105	CcSEcCtD
Trifluoperazine—Rash—Orlistat—obesity	9.87e-05	0.00104	CcSEcCtD
Trifluoperazine—Dermatitis—Orlistat—obesity	9.87e-05	0.00104	CcSEcCtD
Trifluoperazine—Headache—Orlistat—obesity	9.81e-05	0.00104	CcSEcCtD
Trifluoperazine—Hypersensitivity—Bupropion—obesity	9.73e-05	0.00103	CcSEcCtD
Trifluoperazine—Vision blurred—Topiramate—obesity	9.72e-05	0.00103	CcSEcCtD
Trifluoperazine—Tremor—Topiramate—obesity	9.66e-05	0.00102	CcSEcCtD
Trifluoperazine—Rash—Sibutramine—obesity	9.56e-05	0.00101	CcSEcCtD
Trifluoperazine—Dermatitis—Sibutramine—obesity	9.55e-05	0.00101	CcSEcCtD
Trifluoperazine—ABCB1—pituitary gland—obesity	9.54e-05	0.00182	CbGeAlD
Trifluoperazine—ABCB1—adipose tissue—obesity	9.5e-05	0.00181	CbGeAlD
Trifluoperazine—Headache—Sibutramine—obesity	9.49e-05	0.001	CcSEcCtD
Trifluoperazine—Asthenia—Bupropion—obesity	9.48e-05	0.001	CcSEcCtD
Trifluoperazine—Agitation—Topiramate—obesity	9.48e-05	0.001	CcSEcCtD
Trifluoperazine—Pruritus—Bupropion—obesity	9.35e-05	0.000988	CcSEcCtD
Trifluoperazine—Nausea—Orlistat—obesity	9.3e-05	0.000983	CcSEcCtD
Trifluoperazine—Leukopenia—Topiramate—obesity	9.23e-05	0.000976	CcSEcCtD
Trifluoperazine—Acetophenazine—DRD1—obesity	9.02e-05	0.0221	CrCbGaD
Trifluoperazine—Nausea—Sibutramine—obesity	9e-05	0.000951	CcSEcCtD
Trifluoperazine—Cough—Topiramate—obesity	9e-05	0.000951	CcSEcCtD
Trifluoperazine—ABCB1—digestive system—obesity	8.95e-05	0.00171	CbGeAlD
Trifluoperazine—Convulsion—Topiramate—obesity	8.94e-05	0.000945	CcSEcCtD
Trifluoperazine—Dizziness—Bupropion—obesity	8.74e-05	0.000923	CcSEcCtD
Trifluoperazine—Dry mouth—Topiramate—obesity	8.59e-05	0.000908	CcSEcCtD
Trifluoperazine—ABCB1—adrenal gland—obesity	8.52e-05	0.00162	CbGeAlD
Trifluoperazine—Rash—Bupropion—obesity	8.33e-05	0.00088	CcSEcCtD
Trifluoperazine—Dermatitis—Bupropion—obesity	8.32e-05	0.00088	CcSEcCtD
Trifluoperazine—Headache—Bupropion—obesity	8.28e-05	0.000875	CcSEcCtD
Trifluoperazine—Skin disorder—Topiramate—obesity	8.18e-05	0.000864	CcSEcCtD
Trifluoperazine—Antrafenine—PTGS2—obesity	8.03e-05	0.0197	CrCbGaD
Trifluoperazine—Anorexia—Topiramate—obesity	8.02e-05	0.000848	CcSEcCtD
Trifluoperazine—Propericiazine—DRD1—obesity	7.97e-05	0.0195	CrCbGaD
Trifluoperazine—Hypotension—Topiramate—obesity	7.87e-05	0.000831	CcSEcCtD
Trifluoperazine—Nausea—Bupropion—obesity	7.85e-05	0.000829	CcSEcCtD
Trifluoperazine—Insomnia—Topiramate—obesity	7.61e-05	0.000805	CcSEcCtD
Trifluoperazine—Dyspnoea—Topiramate—obesity	7.5e-05	0.000793	CcSEcCtD
Trifluoperazine—Somnolence—Topiramate—obesity	7.48e-05	0.000791	CcSEcCtD
Trifluoperazine—ABCB1—endocrine gland—obesity	7.39e-05	0.00141	CbGeAlD
Trifluoperazine—Decreased appetite—Topiramate—obesity	7.32e-05	0.000773	CcSEcCtD
Trifluoperazine—Fatigue—Topiramate—obesity	7.26e-05	0.000767	CcSEcCtD
Trifluoperazine—Constipation—Topiramate—obesity	7.2e-05	0.000761	CcSEcCtD
Trifluoperazine—Flupentixol—DRD2—obesity	7.16e-05	0.0176	CrCbGaD
Trifluoperazine—Cyamemazine—HTR2C—obesity	6.82e-05	0.0167	CrCbGaD
Trifluoperazine—Clozapine—HRH3—obesity	6.77e-05	0.0166	CrCbGaD
Trifluoperazine—Urticaria—Topiramate—obesity	6.69e-05	0.000707	CcSEcCtD
Trifluoperazine—ABCB1—liver—obesity	6.66e-05	0.00127	CbGeAlD
Trifluoperazine—Body temperature increased—Topiramate—obesity	6.65e-05	0.000703	CcSEcCtD
Trifluoperazine—Acetophenazine—DRD2—obesity	6.36e-05	0.0156	CrCbGaD
Trifluoperazine—Acepromazine—SLC22A1—obesity	6.26e-05	0.0154	CrCbGaD
Trifluoperazine—Hypersensitivity—Topiramate—obesity	6.2e-05	0.000655	CcSEcCtD
Trifluoperazine—Ethopropazine—BCHE—obesity	6.13e-05	0.015	CrCbGaD
Trifluoperazine—Thioproperazine—SLC22A1—obesity	6.12e-05	0.015	CrCbGaD
Trifluoperazine—Asthenia—Topiramate—obesity	6.04e-05	0.000638	CcSEcCtD
Trifluoperazine—Thiothixene—SLC22A1—obesity	6.02e-05	0.0148	CrCbGaD
Trifluoperazine—Pipotiazine—SLC22A1—obesity	6.02e-05	0.0148	CrCbGaD
Trifluoperazine—Pruritus—Topiramate—obesity	5.96e-05	0.000629	CcSEcCtD
Trifluoperazine—Zuclopenthixol—DRD1—obesity	5.71e-05	0.014	CrCbGaD
Trifluoperazine—Dizziness—Topiramate—obesity	5.57e-05	0.000588	CcSEcCtD
Trifluoperazine—Flupentixol—HTR2A—obesity	5.54e-05	0.0136	CrCbGaD
Trifluoperazine—Triflupromazine—DRD1—obesity	5.53e-05	0.0136	CrCbGaD
Trifluoperazine—Rash—Topiramate—obesity	5.31e-05	0.000561	CcSEcCtD
Trifluoperazine—Dermatitis—Topiramate—obesity	5.3e-05	0.00056	CcSEcCtD
Trifluoperazine—Headache—Topiramate—obesity	5.27e-05	0.000557	CcSEcCtD
Trifluoperazine—Acepromazine—DRD1—obesity	5.12e-05	0.0126	CrCbGaD
Trifluoperazine—Triflupromazine—BCHE—obesity	5.02e-05	0.0123	CrCbGaD
Trifluoperazine—Thioproperazine—DRD1—obesity	5e-05	0.0123	CrCbGaD
Trifluoperazine—Nausea—Topiramate—obesity	5e-05	0.000528	CcSEcCtD
Trifluoperazine—Thiothixene—DRD1—obesity	4.92e-05	0.0121	CrCbGaD
Trifluoperazine—Pipotiazine—DRD1—obesity	4.92e-05	0.0121	CrCbGaD
Trifluoperazine—Nefazodone—HTR2C—obesity	4.86e-05	0.0119	CrCbGaD
Trifluoperazine—Propiomazine—DRD4—obesity	4.84e-05	0.0119	CrCbGaD
Trifluoperazine—Trazodone—HTR2C—obesity	4.49e-05	0.011	CrCbGaD
Trifluoperazine—Cyamemazine—HTR2A—obesity	4.34e-05	0.0106	CrCbGaD
Trifluoperazine—Fluphenazine—DRD1—obesity	4.25e-05	0.0104	CrCbGaD
Trifluoperazine—Thiothixene—HTR2C—obesity	4.21e-05	0.0103	CrCbGaD
Trifluoperazine—Mesoridazine—HTR2C—obesity	4.16e-05	0.0102	CrCbGaD
Trifluoperazine—Methotrimeprazine—DRD4—obesity	4.13e-05	0.0101	CrCbGaD
Trifluoperazine—Propiomazine—DRD1—obesity	4.09e-05	0.01	CrCbGaD
Trifluoperazine—Zuclopenthixol—DRD2—obesity	4.03e-05	0.00987	CrCbGaD
Trifluoperazine—Nefazodone—SLC6A4—obesity	4.02e-05	0.00987	CrCbGaD
Trifluoperazine—Prochlorperazine—HTR2C—obesity	4.02e-05	0.00987	CrCbGaD
Trifluoperazine—Loxapine—DRD4—obesity	3.99e-05	0.00979	CrCbGaD
Trifluoperazine—Triflupromazine—DRD2—obesity	3.9e-05	0.00956	CrCbGaD
Trifluoperazine—Quetiapine—DRD4—obesity	3.9e-05	0.00956	CrCbGaD
Trifluoperazine—Trazodone—SLC6A4—obesity	3.72e-05	0.00913	CrCbGaD
Trifluoperazine—Thioridazine—DRD1—obesity	3.67e-05	0.00899	CrCbGaD
Trifluoperazine—Fluphenazine—HTR2C—obesity	3.64e-05	0.00892	CrCbGaD
Trifluoperazine—Acepromazine—DRD2—obesity	3.61e-05	0.00885	CrCbGaD
Trifluoperazine—Promazine—DRD4—obesity	3.58e-05	0.00879	CrCbGaD
Trifluoperazine—Loxapine—HTR1B—obesity	3.55e-05	0.0087	CrCbGaD
Trifluoperazine—Thioproperazine—DRD2—obesity	3.53e-05	0.00865	CrCbGaD
Trifluoperazine—Propiomazine—HTR2C—obesity	3.5e-05	0.00859	CrCbGaD
Trifluoperazine—Methotrimeprazine—DRD1—obesity	3.5e-05	0.00858	CrCbGaD
Trifluoperazine—Pipotiazine—DRD2—obesity	3.47e-05	0.00851	CrCbGaD
Trifluoperazine—Thiothixene—DRD2—obesity	3.47e-05	0.00851	CrCbGaD
Trifluoperazine—Quetiapine—HTR1B—obesity	3.46e-05	0.00849	CrCbGaD
Trifluoperazine—Mesoridazine—DRD2—obesity	3.43e-05	0.0084	CrCbGaD
Trifluoperazine—Loxapine—DRD1—obesity	3.38e-05	0.00829	CrCbGaD
Trifluoperazine—Perphenazine—DRD1—obesity	3.36e-05	0.00825	CrCbGaD
Trifluoperazine—Clozapine—DRD4—obesity	3.35e-05	0.00822	CrCbGaD
Trifluoperazine—Clomipramine—HTR2C—obesity	3.33e-05	0.00816	CrCbGaD
Trifluoperazine—Prochlorperazine—DRD2—obesity	3.32e-05	0.00813	CrCbGaD
Trifluoperazine—Quetiapine—DRD1—obesity	3.3e-05	0.00809	CrCbGaD
Trifluoperazine—Chlorpromazine—SLC22A1—obesity	3.27e-05	0.00801	CrCbGaD
Trifluoperazine—Chlorpromazine—DRD4—obesity	3.15e-05	0.00773	CrCbGaD
Trifluoperazine—Loxapine—ADRB1—obesity	3.14e-05	0.00769	CrCbGaD
Trifluoperazine—Thioridazine—HTR2C—obesity	3.14e-05	0.00769	CrCbGaD
Trifluoperazine—Zuclopenthixol—HTR2A—obesity	3.11e-05	0.00763	CrCbGaD
Trifluoperazine—Nefazodone—HTR2A—obesity	3.09e-05	0.00758	CrCbGaD
Trifluoperazine—Promazine—DRD1—obesity	3.03e-05	0.00744	CrCbGaD
Trifluoperazine—Fluphenazine—DRD2—obesity	3e-05	0.00735	CrCbGaD
Trifluoperazine—Methotrimeprazine—HTR2C—obesity	2.99e-05	0.00734	CrCbGaD
Trifluoperazine—Clozapine—HTR1B—obesity	2.98e-05	0.0073	CrCbGaD
Trifluoperazine—Loxapine—HTR2C—obesity	2.89e-05	0.00709	CrCbGaD
Trifluoperazine—Fluphenazine—CYP2E1—obesity	2.89e-05	0.00708	CrCbGaD
Trifluoperazine—Propiomazine—DRD2—obesity	2.89e-05	0.00707	CrCbGaD
Trifluoperazine—Perphenazine—HTR2C—obesity	2.88e-05	0.00706	CrCbGaD
Trifluoperazine—Trazodone—HTR2A—obesity	2.86e-05	0.00702	CrCbGaD
Trifluoperazine—Clozapine—DRD1—obesity	2.84e-05	0.00696	CrCbGaD
Trifluoperazine—Quetiapine—HTR2C—obesity	2.82e-05	0.00692	CrCbGaD
Trifluoperazine—Acepromazine—HTR2A—obesity	2.79e-05	0.00684	CrCbGaD
Trifluoperazine—Clomipramine—SLC6A4—obesity	2.76e-05	0.00676	CrCbGaD
Trifluoperazine—Thioproperazine—HTR2A—obesity	2.73e-05	0.00668	CrCbGaD
Trifluoperazine—Pipotiazine—HTR2A—obesity	2.68e-05	0.00658	CrCbGaD
Trifluoperazine—Thiothixene—HTR2A—obesity	2.68e-05	0.00658	CrCbGaD
Trifluoperazine—Chlorpromazine—DRD1—obesity	2.67e-05	0.00654	CrCbGaD
Trifluoperazine—Mesoridazine—HTR2A—obesity	2.65e-05	0.00649	CrCbGaD
Trifluoperazine—Promazine—HTR2C—obesity	2.59e-05	0.00636	CrCbGaD
Trifluoperazine—Thioridazine—DRD2—obesity	2.58e-05	0.00634	CrCbGaD
Trifluoperazine—Thioridazine—CYP2E1—obesity	2.49e-05	0.0061	CrCbGaD
Trifluoperazine—Methotrimeprazine—DRD2—obesity	2.47e-05	0.00605	CrCbGaD
Trifluoperazine—Promethazine—DRD2—obesity	2.43e-05	0.00596	CrCbGaD
Trifluoperazine—Clozapine—HTR2C—obesity	2.43e-05	0.00595	CrCbGaD
Trifluoperazine—Chlorpromazine—BCHE—obesity	2.42e-05	0.00594	CrCbGaD
Trifluoperazine—Loxapine—SLC6A4—obesity	2.4e-05	0.00587	CrCbGaD
Trifluoperazine—Loxapine—DRD2—obesity	2.38e-05	0.00584	CrCbGaD
Trifluoperazine—Methotrimeprazine—CYP2E1—obesity	2.37e-05	0.00582	CrCbGaD
Trifluoperazine—Perphenazine—DRD2—obesity	2.37e-05	0.00582	CrCbGaD
Trifluoperazine—Quetiapine—DRD2—obesity	2.33e-05	0.0057	CrCbGaD
Trifluoperazine—Fluphenazine—HTR2A—obesity	2.32e-05	0.00568	CrCbGaD
Trifluoperazine—Chlorpromazine—HTR2C—obesity	2.28e-05	0.0056	CrCbGaD
Trifluoperazine—Propiomazine—HTR2A—obesity	2.23e-05	0.00547	CrCbGaD
Trifluoperazine—Promazine—DRD2—obesity	2.14e-05	0.00524	CrCbGaD
Trifluoperazine—Clomipramine—HTR2A—obesity	2.12e-05	0.0052	CrCbGaD
Trifluoperazine—Clozapine—DRD2—obesity	2e-05	0.00491	CrCbGaD
Trifluoperazine—Thioridazine—HTR2A—obesity	2e-05	0.0049	CrCbGaD
Trifluoperazine—Clozapine—CYP2E1—obesity	1.93e-05	0.00472	CrCbGaD
Trifluoperazine—Acepromazine—ALB—obesity	1.91e-05	0.00468	CrCbGaD
Trifluoperazine—Methotrimeprazine—HTR2A—obesity	1.91e-05	0.00467	CrCbGaD
Trifluoperazine—Chlorpromazine—DRD2—obesity	1.88e-05	0.00461	CrCbGaD
Trifluoperazine—Promethazine—HTR2A—obesity	1.88e-05	0.0046	CrCbGaD
Trifluoperazine—Thioproperazine—ALB—obesity	1.87e-05	0.00457	CrCbGaD
Trifluoperazine—Loxapine—HTR2A—obesity	1.84e-05	0.00451	CrCbGaD
Trifluoperazine—Pipotiazine—ALB—obesity	1.84e-05	0.0045	CrCbGaD
Trifluoperazine—Thiothixene—ALB—obesity	1.84e-05	0.0045	CrCbGaD
Trifluoperazine—Perphenazine—HTR2A—obesity	1.83e-05	0.00449	CrCbGaD
Trifluoperazine—Chlorpromazine—CYP2E1—obesity	1.81e-05	0.00444	CrCbGaD
Trifluoperazine—Quetiapine—HTR2A—obesity	1.8e-05	0.00441	CrCbGaD
Trifluoperazine—Promazine—HTR2A—obesity	1.65e-05	0.00405	CrCbGaD
Trifluoperazine—Clozapine—HTR2A—obesity	1.55e-05	0.00379	CrCbGaD
Trifluoperazine—Chlorpromazine—HTR2A—obesity	1.45e-05	0.00357	CrCbGaD
Trifluoperazine—Clomipramine—ALB—obesity	1.45e-05	0.00356	CrCbGaD
Trifluoperazine—Chlorpromazine—ALB—obesity	9.95e-06	0.00244	CrCbGaD
Trifluoperazine—CALM1—Immune System—MAPK8—obesity	1.03e-06	9.91e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—PIK3CA—obesity	1.03e-06	9.9e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CG—obesity	1.03e-06	9.89e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CG—obesity	1.03e-06	9.89e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PIK3R1—obesity	1.02e-06	9.82e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—NOS3—obesity	1.02e-06	9.82e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—NOS3—obesity	1.02e-06	9.82e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PIK3R1—obesity	1.02e-06	9.82e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—LPL—obesity	1.02e-06	9.78e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IRS1—obesity	1.02e-06	9.78e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IRS1—obesity	1.02e-06	9.78e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—PIK3CA—obesity	1.02e-06	9.74e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—POMC—obesity	1.01e-06	9.73e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—PIK3CA—obesity	1.01e-06	9.72e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—INS—obesity	1.01e-06	9.68e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—AKT1—obesity	1e-06	9.63e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—AKT1—obesity	1e-06	9.63e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PIK3CB—obesity	1e-06	9.59e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MTOR—obesity	1e-06	9.59e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—PIK3CA—obesity	9.97e-07	9.56e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GPX1—obesity	9.95e-07	9.54e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—PIK3CA—obesity	9.94e-07	9.54e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCL2—obesity	9.93e-07	9.52e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MMP9—obesity	9.9e-07	9.5e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MMP9—obesity	9.85e-07	9.45e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PIK3CB—obesity	9.84e-07	9.44e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MTOR—obesity	9.84e-07	9.44e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MTOR—obesity	9.82e-07	9.42e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PIK3CB—obesity	9.82e-07	9.42e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—POMC—obesity	9.81e-07	9.42e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—POMC—obesity	9.81e-07	9.42e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PIK3CB—obesity	9.77e-07	9.37e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—STAT3—obesity	9.76e-07	9.37e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—INS—obesity	9.76e-07	9.36e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—INS—obesity	9.76e-07	9.36e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IGF1—obesity	9.76e-07	9.36e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKT2—obesity	9.75e-07	9.36e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CD36—obesity	9.69e-07	9.29e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PTGS2—obesity	9.68e-07	9.28e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CG—obesity	9.66e-07	9.27e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MTOR—obesity	9.66e-07	9.27e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PIK3CB—obesity	9.66e-07	9.27e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MTOR—obesity	9.63e-07	9.24e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PIK3CB—obesity	9.63e-07	9.24e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MAPK8—obesity	9.63e-07	9.24e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCL2—obesity	9.6e-07	9.21e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCL2—obesity	9.6e-07	9.21e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—AKT1—obesity	9.6e-07	9.21e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MAPK8—obesity	9.58e-07	9.19e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—AKT1—obesity	9.55e-07	9.16e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PIK3CB—obesity	9.45e-07	9.06e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PIK3CB—obesity	9.45e-07	9.06e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—STAT3—obesity	9.44e-07	9.06e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—STAT3—obesity	9.44e-07	9.06e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IGF1—obesity	9.44e-07	9.06e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IGF1—obesity	9.44e-07	9.06e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKT2—obesity	9.43e-07	9.05e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKT2—obesity	9.43e-07	9.05e-06	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—PIK3CA—obesity	9.38e-07	9e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CD—obesity	9.37e-07	8.99e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTGS2—obesity	9.36e-07	8.98e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTGS2—obesity	9.36e-07	8.98e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PPARG—obesity	9.32e-07	8.94e-06	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—AKT1—obesity	9.28e-07	8.91e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SERPINE1—obesity	9.27e-07	8.89e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—POMC—obesity	9.2e-07	8.82e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—MTHFR—obesity	9.18e-07	8.81e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—INS—obesity	9.14e-07	8.77e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL6—obesity	9.14e-07	8.77e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—AKT1—obesity	9.13e-07	8.76e-06	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—AKT1—obesity	9.11e-07	8.74e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CD—obesity	9.06e-07	8.7e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CD—obesity	9.06e-07	8.7e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TYK2—obesity	9.01e-07	8.65e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—STAT3—obesity	9.01e-07	8.65e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PPARA—obesity	9e-07	8.64e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL6—obesity	8.99e-07	8.63e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL6—obesity	8.97e-07	8.61e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—AKT1—obesity	8.97e-07	8.6e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SERPINE1—obesity	8.96e-07	8.6e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SERPINE1—obesity	8.96e-07	8.6e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—AKT1—obesity	8.94e-07	8.58e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—RHOA—obesity	8.94e-07	8.58e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3R1—obesity	8.85e-07	8.49e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NOS3—obesity	8.85e-07	8.49e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL6—obesity	8.83e-07	8.47e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL6—obesity	8.8e-07	8.45e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—STAT3—obesity	8.8e-07	8.44e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—STAT3—obesity	8.76e-07	8.4e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AGT—obesity	8.72e-07	8.37e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TYK2—obesity	8.72e-07	8.37e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TYK2—obesity	8.72e-07	8.37e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—STAT3—obesity	8.72e-07	8.36e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—STAT3—obesity	8.72e-07	8.36e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MMP9—obesity	8.69e-07	8.34e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—RHOA—obesity	8.65e-07	8.3e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—RHOA—obesity	8.65e-07	8.3e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NOS3—obesity	8.56e-07	8.21e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NOS3—obesity	8.56e-07	8.21e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3R1—obesity	8.56e-07	8.21e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3R1—obesity	8.56e-07	8.21e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MMP9—obesity	8.55e-07	8.2e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—APOE—obesity	8.54e-07	8.2e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MMP9—obesity	8.53e-07	8.19e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CD—obesity	8.49e-07	8.15e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CAV1—obesity	8.47e-07	8.12e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MAPK8—obesity	8.45e-07	8.11e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—APOA1—obesity	8.45e-07	8.1e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—AKT1—obesity	8.43e-07	8.09e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—PIK3CA—obesity	8.43e-07	8.09e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MMP9—obesity	8.4e-07	8.06e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—ALB—obesity	8.38e-07	8.04e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MYC—obesity	8.37e-07	8.03e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MMP9—obesity	8.37e-07	8.03e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—TGFB1—obesity	8.35e-07	8.02e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MAPK8—obesity	8.32e-07	7.98e-06	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL6—obesity	8.3e-07	7.97e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MAPK8—obesity	8.3e-07	7.96e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—AKT1—obesity	8.29e-07	7.96e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—AKT1—obesity	8.28e-07	7.94e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MYC—obesity	8.18e-07	7.85e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MTOR—obesity	8.17e-07	7.84e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CB—obesity	8.17e-07	7.84e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MAPK8—obesity	8.17e-07	7.83e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TGFB1—obesity	8.16e-07	7.83e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—PIK3CA—obesity	8.15e-07	7.82e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—PIK3CA—obesity	8.15e-07	7.82e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—AKT1—obesity	8.14e-07	7.81e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MAPK8—obesity	8.14e-07	7.81e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MYC—obesity	8.14e-07	7.81e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—AKT1—obesity	8.12e-07	7.79e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TGFB1—obesity	8.12e-07	7.79e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MYC—obesity	8.1e-07	7.77e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MYC—obesity	8.1e-07	7.77e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	8.09e-07	7.76e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TGFB1—obesity	8.08e-07	7.75e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TGFB1—obesity	8.08e-07	7.75e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—NOS3—obesity	8.02e-07	7.69e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3R1—obesity	8.02e-07	7.69e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CB—obesity	7.9e-07	7.58e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MTOR—obesity	7.9e-07	7.58e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MTOR—obesity	7.9e-07	7.58e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CB—obesity	7.9e-07	7.58e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—STAT3—obesity	7.73e-07	7.41e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CG—obesity	7.71e-07	7.4e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—PIK3CA—obesity	7.7e-07	7.39e-06	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AKT1—obesity	7.66e-07	7.35e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—STAT3—obesity	7.6e-07	7.29e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—STAT3—obesity	7.59e-07	7.28e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—STAT3—obesity	7.47e-07	7.16e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL6—obesity	7.46e-07	7.16e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—PIK3CA—obesity	7.45e-07	7.15e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—PIK3CA—obesity	7.45e-07	7.15e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—STAT3—obesity	7.44e-07	7.14e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PPARG—obesity	7.44e-07	7.14e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CB—obesity	7.4e-07	7.1e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—POMC—obesity	7.34e-07	7.04e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—obesity	7.33e-07	7.04e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—INS—obesity	7.3e-07	7e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL6—obesity	7.22e-07	6.93e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL6—obesity	7.22e-07	6.93e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MYC—obesity	7.18e-07	6.89e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TGFB1—obesity	7.16e-07	6.87e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PIK3CA—obesity	7.11e-07	6.82e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MMP9—obesity	7.1e-07	6.81e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MYC—obesity	7.06e-07	6.78e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MYC—obesity	7.05e-07	6.76e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TGFB1—obesity	7.05e-07	6.76e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TGFB1—obesity	7.03e-07	6.75e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—PIK3CA—obesity	6.94e-07	6.66e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MYC—obesity	6.94e-07	6.66e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TGFB1—obesity	6.92e-07	6.64e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MYC—obesity	6.92e-07	6.64e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—PIK3CA—obesity	6.91e-07	6.63e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MAPK8—obesity	6.9e-07	6.62e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TGFB1—obesity	6.9e-07	6.62e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—AKT1—obesity	6.88e-07	6.61e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PIK3CA—obesity	6.88e-07	6.6e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PIK3CA—obesity	6.88e-07	6.6e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MMP9—obesity	6.87e-07	6.59e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MMP9—obesity	6.87e-07	6.59e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL6—obesity	6.82e-07	6.54e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CD—obesity	6.78e-07	6.5e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ALB—obesity	6.69e-07	6.42e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MAPK8—obesity	6.68e-07	6.41e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MAPK8—obesity	6.68e-07	6.41e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—AKT1—obesity	6.66e-07	6.39e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—AKT1—obesity	6.66e-07	6.39e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL6—obesity	6.6e-07	6.33e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL6—obesity	6.6e-07	6.33e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3R1—obesity	6.4e-07	6.14e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—NOS3—obesity	6.4e-07	6.14e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—STAT3—obesity	6.31e-07	6.06e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IL6—obesity	6.3e-07	6.04e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—AKT1—obesity	6.29e-07	6.04e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL6—obesity	6.15e-07	5.9e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL6—obesity	6.12e-07	5.87e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—STAT3—obesity	6.11e-07	5.86e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—STAT3—obesity	6.11e-07	5.86e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PIK3CA—obesity	6.1e-07	5.85e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IL6—obesity	6.09e-07	5.84e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IL6—obesity	6.09e-07	5.84e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—AKT1—obesity	6.09e-07	5.84e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—AKT1—obesity	6.09e-07	5.84e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PIK3CA—obesity	6e-07	5.75e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PIK3CA—obesity	5.98e-07	5.74e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PIK3CA—obesity	5.95e-07	5.71e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CB—obesity	5.91e-07	5.67e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PIK3CA—obesity	5.89e-07	5.65e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PIK3CA—obesity	5.87e-07	5.63e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MYC—obesity	5.86e-07	5.63e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—obesity	5.85e-07	5.62e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TGFB1—obesity	5.85e-07	5.61e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—AKT1—obesity	5.81e-07	5.57e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PIK3CA—obesity	5.76e-07	5.53e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PIK3CA—obesity	5.76e-07	5.53e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MYC—obesity	5.67e-07	5.44e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MYC—obesity	5.67e-07	5.44e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AKT1—obesity	5.67e-07	5.44e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TGFB1—obesity	5.66e-07	5.43e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TGFB1—obesity	5.66e-07	5.43e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AKT1—obesity	5.64e-07	5.41e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—AKT1—obesity	5.62e-07	5.39e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—AKT1—obesity	5.62e-07	5.39e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL6—obesity	5.4e-07	5.18e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6—obesity	5.31e-07	5.1e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6—obesity	5.3e-07	5.08e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6—obesity	5.21e-07	5e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6—obesity	5.2e-07	4.99e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AKT1—obesity	4.98e-07	4.78e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CA—obesity	4.98e-07	4.78e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AKT1—obesity	4.9e-07	4.7e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AKT1—obesity	4.89e-07	4.69e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—AKT1—obesity	4.86e-07	4.67e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CA—obesity	4.82e-07	4.62e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CA—obesity	4.82e-07	4.62e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AKT1—obesity	4.81e-07	4.62e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AKT1—obesity	4.8e-07	4.6e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—AKT1—obesity	4.71e-07	4.51e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—AKT1—obesity	4.71e-07	4.51e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CA—obesity	4.51e-07	4.33e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6—obesity	4.41e-07	4.23e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6—obesity	4.26e-07	4.09e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6—obesity	4.26e-07	4.09e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKT1—obesity	4.07e-07	3.9e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKT1—obesity	3.93e-07	3.77e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKT1—obesity	3.93e-07	3.77e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—AKT1—obesity	3.69e-07	3.54e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CA—obesity	3.6e-07	3.46e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AKT1—obesity	2.94e-07	2.82e-06	CbGpPWpGaD
